To evaluate the efficacy and safety of opioids for analgesic therapy for people with osteoarthritis. Systematic review and meta‐analysis of randomised, placebo‐controlled trials of opioid therapies for treating the pain of osteoarthritis. The primary outcome was medium term pain relief (six weeks to less than [...]
Understanding barriers and enablers to monitoring and deprescribing opioids will enable the development of tailored interventions to improve both practices. To perform a qualitative evidence synthesis of the barriers and enablers to monitoring ongoing appropriateness and deprescribing of opioids for chronic non-cancer pain (CNCP) and [...]
Deprescribing is the process of reducing or discontinuing unnecessary or harmful medicines. To address the ‘opioid epidemic’, clinical practice guidelines now discourage the initial prescription of opioid analgesics for chronic non-cancer pain and strategies such as the introduction of Prescription Drug Monitoring Programs may reduce [...]
The article by McCarty and colleagues discusses neonatal abstinence syndrome (NAS), including opioid withdrawal syndrome, and the use of physical therapist treatment of infants with this condition. Similar to these authors, we are concerned about the “opioid crisis” and are open to the idea that [...]
Guidelines now discourage opioid analgesics for chronic noncancer pain because the benefits frequently do not outweigh the harms. We aimed to determine the proportion of patients with chronic noncancer pain who are prescribed an opioid, the types prescribed and factors associated with prescribing. Database searches [...]